Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,576 | 1,106 | 99.7% |
| Education | $53.61 | 11 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,220 | 186 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,763 | 109 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,515 | 94 | $0 (2024) |
| ABBVIE INC. | $1,201 | 90 | $0 (2024) |
| PFIZER INC. | $1,051 | 77 | $0 (2024) |
| GlaxoSmithKline, LLC. | $972.44 | 68 | $0 (2024) |
| Lilly USA, LLC | $643.62 | 56 | $0 (2024) |
| Merck Sharp & Dohme LLC | $586.30 | 51 | $0 (2024) |
| Amgen Inc. | $505.86 | 32 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $465.59 | 30 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,296 | 140 | Boehringer Ingelheim Pharmaceuticals, Inc. ($309.74) |
| 2023 | $1,817 | 116 | AbbVie Inc. ($316.67) |
| 2022 | $1,972 | 129 | Novo Nordisk Inc ($348.62) |
| 2021 | $1,727 | 127 | Novo Nordisk Inc ($275.44) |
| 2020 | $1,847 | 142 | Novo Nordisk Inc ($299.06) |
| 2019 | $1,848 | 158 | Novo Nordisk Inc ($291.13) |
| 2018 | $2,100 | 150 | AstraZeneca Pharmaceuticals LP ($329.42) |
| 2017 | $2,022 | 155 | AstraZeneca Pharmaceuticals LP ($357.72) |
All Payment Transactions
1,117 individual payment records from CMS Open Payments — Page 1 of 45
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: DIABETES | ||||||
| 12/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/17/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug), Linzess | Food and Beverage | Cash or cash equivalent | $19.37 | General |
| Category: GI | ||||||
| 12/16/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: UROLOGY | ||||||
| 12/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $29.73 | General |
| Category: DIABETES | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.60 | General |
| Category: Cardiovascular | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: RESPIRATORY | ||||||
| 12/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: Iron Deficiency Anemia | ||||||
| 12/03/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: VACCINES | ||||||
| 12/02/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $8.89 | General |
| Category: PAIN | ||||||
| 11/26/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: Respiratory | ||||||
| 11/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: Cardio-renal | ||||||
| 11/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Bone Health | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: VACCINES | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $1.63 | General |
| Category: VACCINES | ||||||
| 11/12/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $5.99 | General |
| Category: Inflammation | ||||||
| 11/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: DIABETES | ||||||
| 11/01/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: VACCINES | ||||||
| 10/31/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $7.37 | General |
| Category: VACCINES | ||||||
| 10/30/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $4.91 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,886 | 3,280 | $415,775 | $201,642 |
| 2022 | 22 | 1,878 | 3,148 | $414,164 | $200,638 |
| 2021 | 23 | 2,488 | 3,744 | $428,996 | $217,452 |
| 2020 | 26 | 2,245 | 3,725 | $452,640 | $185,894 |
All Medicare Procedures & Services
96 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 460 | 1,179 | $206,325 | $90,274 | 43.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 282 | 282 | $49,350 | $32,952 | 66.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 56 | 56 | $21,784 | $15,837 | 72.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 156 | 236 | $28,320 | $13,433 | 47.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 169 | 170 | $12,750 | $12,149 | 95.3% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 25 | 26 | $14,118 | $5,238 | 37.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 177 | 178 | $12,251 | $5,092 | 41.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 15 | 101 | $10,504 | $4,671 | 44.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 24 | 24 | $7,440 | $3,487 | 46.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 28 | 33 | $7,425 | $3,080 | 41.5% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 18 | 19 | $7,296 | $2,926 | 40.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 16 | 16 | $4,080 | $2,393 | 58.7% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 61 | 62 | $4,898 | $2,352 | 48.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 57 | 57 | $2,166 | $1,649 | 76.1% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 44 | 107 | $5,136 | $1,526 | 29.7% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 43 | 87 | $3,654 | $1,358 | 37.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 57 | 130 | $5,330 | $1,089 | 20.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 19 | 20 | $3,000 | $854.93 | 28.5% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 13 | 15 | $1,680 | $465.66 | 27.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 37 | 38 | $3,534 | $346.56 | 9.8% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 16 | 16 | $800.00 | $243.00 | 30.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 58 | 69 | $2,139 | $151.80 | 7.1% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 23 | 46 | $230.00 | $48.55 | 21.1% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 32 | 313 | $1,565 | $25.09 | 1.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 487 | 1,245 | $217,105 | $95,796 | 44.1% |
About Dr. Clarence Alexander, MD
Dr. Clarence Alexander, MD is a Family Medicine healthcare provider based in Florence, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1154394153.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Clarence Alexander, MD has received a total of $15,630 in payments from pharmaceutical and medical device companies, with $2,296 received in 2024. These payments were reported across 1,117 transactions from 62 companies. The most common payment nature is "Food and Beverage" ($15,576).
As a Medicare-enrolled provider, Alexander has provided services to 8,497 Medicare beneficiaries, totaling 13,897 services with total Medicare billing of $805,625. Data is available for 4 years (2020–2023), covering 96 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Florence, SC
- Active Since 02/09/2006
- Last Updated 02/08/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1154394153
Products in Payments
- Ozempic (Drug) $1,141
- TRADJENTA (Drug) $972.86
- FARXIGA (Drug) $724.62
- JARDIANCE (Drug) $695.54
- UBRELVY (Drug) $521.09
- TRELEGY ELLIPTA (Drug) $511.06
- VRAYLAR (Drug) $389.81
- ELIQUIS (Drug) $379.04
- XARELTO (Drug) $361.44
- TRULICITY (Drug) $332.75
- JANUVIA (Drug) $310.37
- LINZESS (Drug) $285.55
- Rybelsus (Drug) $280.01
- XIFAXAN (Drug) $271.35
- Victoza (Drug) $259.36
- ENTRESTO (Drug) $258.17
- CHANTIX (Drug) $257.65
- SYMBICORT (Drug) $238.93
- GEMTESA (Drug) $237.01
- Saxenda (Drug) $221.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Florence
Dr. Bradley Gray
Family Medicine — Payments: $23,764
Cory Smith, Md, MD
Family Medicine — Payments: $16,619
Donald Behling, Md, MD
Family Medicine — Payments: $16,401
Dr. Guy Mcclary, Md, MD
Family Medicine — Payments: $15,201
Dr. Edward Schumann, Md, MD
Family Medicine — Payments: $14,923
Dr. Ralph Crowe, M.d, M.D
Family Medicine — Payments: $14,896